Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals

Experimental Neurology

Volumn 234, Issue 2, 2012, Pages 382-388

  Shih, Yen Yu I ^a,b,c   Chiang, Yun Chen ^b,d   Shyu, Bai Chuang ^b   Jaw, Fu Shan ^d   Duong, Timothy Q ^c   Chang, Chen ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

CBV; Eticlopride; FMRI; Morphine; Naloxone; Striatum; Vasoconstriction

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; ENDORPHIN; ETICLOPRIDE; FERUCARBOTRAN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL PRESSURE; ARTICLE; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROSTIMULATION; EVOKED RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MALE; NEUROMODULATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; CEREBROVASCULAR CIRCULATION; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; MAGNETIC RESONANCE IMAGING; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN; RATS; RATS, WISTAR; SALICYLAMIDES; SYNAPTIC TRANSMISSION; VASOCONSTRICTION;

EID: 84862784589     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.042     Document Type: Article

References (45)

1. Attwell D., Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci. 2002, 25:621-625.
2. Becerra L., Breiter H.C., Wise R., Gonzalez R.G., Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron 2001, 32:927-946.
3. Bingel U., Glascher J., Weiller C., Buchel C. Somatotopic representation of nociceptive information in the putamen: an event-related fMRI study. Cereb. Cortex 2004, 14:1340-1345.
4. Borras M.C., Becerra L., Ploghaus A., Gostic J.M., DaSilva A., Gonzalez R.G., Borsook D. fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. J. Neurophysiol. 2004, 91:2723-2733.
5. Casey K.L. Forebrain mechanisms of nociception and pain: analysis through imaging. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7668-7674.
6. Chang C., Shyu B.C. A fMRI study of brain activations during non-noxious and noxious electrical stimulation of the sciatic nerve of rats. Brain Res. 2001, 897:71-81.
7. Chen Y.C., Choi J.K., Andersen S.L., Rosen B.R., Jenkins B.G. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 2005, 180:705-715.
8. Chen C.C., Shih Y.Y., Mo K.C., Yao N.W., Lin Z.J., Huang C.H., Shyu B.C., Chang C. Mapping dopaminergic denervation in Parkinson disease in vivo and in situ: the visualization of structural details by CBV-weighted fMRI. J. Cereb. Blood Flow Metab. 2009, 29:S607-S608.
9. Choi J.K., Chen Y.I., Hamel E., Jenkins B.G. Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. NeuroImage 2006, 30:700-712.
10. Chudler E.H., Dong W.K. The role of the basal ganglia in nociception and pain. Pain 1995, 60:3-38.
11. Clark W.G. Influence of opioids on central thermoregulatory mechanisms. Pharmacol. Biochem. Behav. 1979, 10:609-613.
12. de la Fuente-Fernandez R., Schulzer M., Stoessl A.J. The placebo effect in neurological disorders. Lancet Neurol. 2002, 1:85-91.
13. Elmer G.I., Pieper J.O., Rubinstein M., Low M.J., Grandy D.K., Wise R.A. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J. Neurosci. 2002, 22:RC224.
14. Fennessy M.R., Rattray J.F. Cardiovascular effects of intravenous morphine in the anaesthetized rat. Eur. J. Pharmacol. 1971, 14:1-8.
15. Hagelberg N., Kajander J.K., Nagren K., Hinkka S., Hietala J., Scheinin H. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse 2002, 45:25-30.
16. Hagelberg N., Aalto S., Kajander J., Oikonen V., Hinkka S., Nagren K., Hietala J., Scheinin H. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects. Pain 2004, 109:86-93.
17. Hagelberg N., Jaaskelainen S.K., Martikainen I.K., Mansikka H., Forssell H., Scheinin H., Hietala J., Pertovaara A. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur. J. Pharmacol. 2004, 500:187-192.
18. Inoue M., Katsumi Y., Hayashi T., Mukai T., Ishizu K., Hashikawa K., Saji H., Fukuyama H. Sensory stimulation accelerates dopamine release in the basal ganglia. Brain Res. 2004, 1026:179-184.
19. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992, 12:483-488.
20. Kennan R.P., Scanley B.E., Innis R.B., Gore J.C. Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects. Magn. Reson. Med. 1998, 40:840-846.
21. Lin M.T., Wu J.J., Tsay B.L. Effects of kainic acid injections in the striatum on physiologic and behavioral functions in conscious rats. Exp. Neurol. 1984, 83:71-83.
22. Liu C.H., Greve D.N., Dai G., Marota J.J., Mandeville J.B. Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation. NeuroImage 2007, 34:1042-1053.
23. Lowe A.S., Beech J.S., Williams S.C. Small animal, whole brain fMRI: innocuous and nociceptive forepaw stimulation. NeuroImage 2007, 35:719-728.
24. Lu H., Scholl C.A., Zuo Y., Stein E.A., Yang Y. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T. Magn. Reson. Med. 2007, 58:616-621.
25. Magnusson J.E., Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res. 2000, 855:260-266.
26. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388:586-589.
27. Mandeville J.B., Marota J.J., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B.R., Weisskoff R.M. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998, 39:615-624.
28. Martin J.R., Takemori A.E. Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice. Eur. J. Pharmacol. 1985, 119:75-84.
29. Morrow T.J., Paulson P.E., Danneman P.J., Casey K.L. Regional changes in forebrain activation during the early and late phase of formalin nociception: analysis using cerebral blood flow in the rat. Pain 1998, 75:355-365.
30. Pawela C.P., Biswal B.B., Hudetz A.G., Li R., Jones S.R., Cho Y.R., Matloub H.S., Hyde J.S. Interhemispheric neuroplasticity following limb deafferentation detected by resting-state functional connectivity magnetic resonance imaging (fcMRI) and functional magnetic resonance imaging (fMRI). NeuroImage 2010, 49:2467-2478.
31. Rooney K.F., Armstrong R.A., Sewell R.D. Increased dopamine receptor sensitivity in the rat following acute administration of sufentanil, U50,488H and D-Ala2-D-Leu5-enkephalin. Naunyn-Schmiedebergs Arch. Pharmacol. 1991, 343:458-462.
32. Shah Y.B., Haynes L., Prior M.J., Marsden C.A., Morris P.G., Chapman V. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) 2005, 180:761-773.
33. Shen Q., Ren H., Duong T.Q. CBF, BOLD, CBV, and CMRO(2) fMRI signal temporal dynamics at 500-msec resolution. J. Magn. Reson. Imaging 2008, 27:599-606.
34. Shih Y.Y., Chen Y.Y., Chen J.C., Chang C., Jaw F.S. ISPMER: integrated system for combined PET, MRI, and electrophysiological recording in somatosensory studies in rats. Nucl. Instrum. Meth. A 2007, 580:938-943.
35. Shih Y.Y., Chen Y.Y., Chen C.C., Chen J.C., Chang C., Jaw F.S. Whole-brain functional magnetic resonance imaging mapping of acute nociceptive responses induced by formalin in rats using atlas registration-based event-related analysis. J. Neurosci. Res. 2008, 86:1801-1811.
36. Shih Y.Y., Chen C.C., Shyu B.C., Lin Z.J., Chiang Y.C., Jaw F.S., Chen Y.Y., Chang C. A new scenario for negative functional magnetic resonance imaging signals: endogenous neurotransmission. J. Neurosci. 2009, 29:3036-3044.
37. Shih Y.Y., Wey H.Y., De La Garza B.H., Duong T.Q. Striatal and cortical BOLD, blood flow, blood volume, oxygen consumption, and glucose consumption changes in noxious forepaw electrical stimulation. J. Cereb. Blood Flow Metab. 2011, 31:832-841.
38. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1544-1549.
39. Sun J.J., Yang J.W., Shyu B.C. Current source density analysis of laser heat-evoked intra-cortical field potentials in the primary somatosensory cortex of rats. Neuroscience 2006, 140:1321-1336.
40. Tempel A., Zukin R.S. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:4308-4312.
41. Thobois S., Hassoun W., Ginovart N., Garcia-Larrea L., Le Cavorsin M., Guillouet S., Bonnefoi F., Costes N., Lavenne F., Broussolle E., Leviel V. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study. Neurosci. Lett. 2004, 368:46-51.
42. Tuor U.I., McKenzie E., Tomanek B. Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats. Magn. Reson. Imaging 2002, 20:707-712.
43. Ushijima I., Tanaka M., Tsuda A., Koga S., Nagasaki N. Differential effects of morphine on core temperature in stressed and non-stressed rats. Eur. J. Pharmacol. 1985, 112:331-337.
44. Wu E.X., Tang H., Jensen J.H. Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models. NMR Biomed. 2004, 17:478-483.
45. Zhao F., Zhao T., Zhou L., Wu Q., Hu X. BOLD study of stimulation-induced neural activity and resting-state connectivity in medetomidine-sedated rat. NeuroImage 2008, 39:248-260.